The study concludes that manipulating the SNHG6/miR-944/KPNA5 pathway could be a viable strategy for overcoming GEM resistance in pancreatic cancer, thereby potentially improving patient outcomes [144]. Here, SNHG6 is linked to pancreatic neoplasm.